BSE filing, BSE: 544220. Summary written from the filing by ALFA Finder's alert engine.
Clinitech Laboratory Ltd: key numbers
- Share price
- ₹30.85
- Market cap
- ₹7.04 Cr
- Revenue (annual)
- ₹9.49 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 16.9×Sector 34.1×
- Promoter holding
- 64.62%
- FII holding
- 0.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clinitech Laboratory Ltd
All →Clinitech Laboratory Other Announcement
Clinitech Laboratory submitted a certificate confirming the non-applicability of SEBI Regulation 23 regarding Related Party Transactions. This is for the half-year ended September 30, 2026.
Clinitech Laboratory Other Announcement
Clinitech Laboratory Limited filed a Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming no rematerialization requests were received.
Clinitech Laboratory Annual General Meeting
Clinitech Laboratory Limited held its 16th Annual General Meeting on September 24, 2026. Shareholders transacted items including financial statement adoption and director re-appointment.
Clinitech Laboratory Annual General Meeting
Clinitech Laboratory Limited has released its Annual Report for FY 2025-26 and notice for the Annual General Meeting to be held on September 24, 2026.
Clinitech Laboratory Board Meeting Outcome
Clinitech Laboratory Limited's board approved the FY 2025-26 report and convened its 16th Annual General Meeting. The meeting also finalized book closure dates and appointed a voting scrutinizer.
Clinitech Laboratory Board Meeting Date
Clinitech Laboratory Ltd scheduled a Board Meeting for August 17, 2026. The board will discuss director appointments and the 16th AGM.
Other promoter reclassification announcements
All →Kkalpana Plastick Promoter Reclassification
Kkalpana Plastick reports promoters Bbigplas Poly and Sarla Surana reclassified to public after Ashish Begwani's open offer. Begwani, acquiring 40.12 lakh shares, becomes sole promoter.
Thirumalai Chemicals Promoter Reclassification
Thirumalai Chemicals received requests from two promoter group members, Narayan Santhanam and Deepa Ajay, to reclassify 100,000 shares (0.08%) as public. The board will consider the requests at its next meeting.
Star Health and Allied Insurance Company Promoter Reclassification
Star Health's board approved reclassifying Sthitaprajna Advisors LLP from promoter group to public shareholder category. The move is subject to requisite regulatory approvals.
SBI Funds Management Promoter Reclassification
SBI Funds Management's shareholding filing seeks Regulation 31A reclassification of Indian Digital Payment Intelligence Corporation from promoter group to public. No monetary value is involved.
GSPL Transmission Promoter Reclassification
GSPL Transmission received a request from promoter GSEG to reclassify its 0.14% stake from Promoter to Public category under Regulation 31A. Reclassification awaits Board and exchange approval.
BGR Energy Systems Promoter Reclassification
BGR Energy Systems received a Reg 31A reclassification request from promoter S.K. Sridhar to move 104 shares (0.0001%) from Promoter to Public category.